Trends in the utilization of imaging for upper tract urothelial carcinoma

被引:14
作者
Mohapatra, Anand [1 ]
Vemana, Goutham [2 ]
Bhayani, Sam [1 ]
Baty, Jack [3 ]
Vetter, Joel [1 ]
Strope, Seth A. [1 ]
机构
[1] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA
[2] Urol Associates Houston, Houston, TX USA
[3] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
Upper Tract Urothelial Cancer; Imaging; Diagnosis; Endoscopy; Surgery; TRANSITIONAL-CELL-CARCINOMA; BOLUS MDCT UROGRAPHY; TOMOGRAPHY UROGRAPHY; CT UROGRAPHY; GUIDELINES; OUTCOMES;
D O I
10.1016/j.urolonc.2015.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To evaluate the changes in use of the different imaging modalities for diagnosing upper tract urothelial carcinoma (UTUC) and assess how these changes have affected tumor stage at the time of surgery. Materials and methods: We assessed the Surveillance, Epidemiology, and End Results (SEER) cancer registry and linked Medicare claims data (1992-2009) for 5377 patients who underwent surgery for UTUC. We utilized International Classification of Disease Oncology 3 codes to identify UTUC. International Classification of Disease, ninth Revision, Clinical Modification and Current Procedure Terminology codes identified surgical treatment and imaging modalities. We assessed for use of intravenous pyelography, retrograde pyelography (RGP), computed tomography urography (CTU), magnetic resonance urography (MRU), and endoscopy. For each modality, patients were categorized as having received the modality at least once or not at all. Patient characteristics were compared using chi-squared tests. Usage of imaging modalities and tumor stage was trended using Cochran-Armitage tests. We stratified our data into 2 multivariate logistic regression models to determine the effect of imaging modalities on tumor stage: 1992 to 1999 with all modalities except MRU, and 2000 to 2009 with all modalities. Results: Our patient population was predominantly White males of more than 70 years old. Intravenous pyelography and RGP declined in use (62% and 72% in 1992 vs. 6% and 58% in 2009, respectively) while computed tomography urography, MRU, and endoscopy increased in use (2%, 0%, and 37% in 1992 vs. 44%, 6%, and 66% in 2009, respectively). In both regression analyses, endoscopy was associated with lower-stage tumors. In the 2000 to 2009 model, RGP was associated with lower-stage tumors, and MRU was associated with higher-stage tumors. Finally, our data showed an increasing number of modalities utilized for each patient (1% receiving 4 modalities in 1992 vs. 20% in 2009). Conclusions: We found trends toward the utilization of newer imaging modalities to diagnose UTUC and more modalities per patient. Endoscopy and RGP were associated with smaller tumors, whereas MRU was associated with larger tumors. Further studies are needed to evaluate the utility of the different modalities in diagnosing UTUC. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:236.e23 / 236.e28
页数:6
相关论文
共 50 条
  • [1] Imaging in Upper Tract Urothelial Carcinoma: A Review
    Tsikitas, Lucas A.
    Hopstone, Michelle Diamond
    Raman, Alex
    Duddalwar, Vinay
    CANCERS, 2023, 15 (20)
  • [2] Imaging of Upper Tract Urothelial Carcinoma
    Nakai, Hirotsugu
    Takahashi, Hiroaki
    V. Wellnitz, Clinton
    Stanton, Melissa L.
    Takahashi, Naoki
    Kawashima, Akira
    RADIOGRAPHICS, 2024, 44 (11)
  • [3] Trends of incidence and prognosis of upper tract urothelial carcinoma
    Wu, Jianping
    Chen, Shuqiu
    Wu, Xiaoli
    Mao, Weipu
    Wang, Yali
    Xu, Bin
    Zheng, Donghui
    Chen, Ming
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (05) : 607 - 619
  • [4] Imaging for upper tract urothelial carcinoma: update of the evidence and a glimpse into the future
    Laukhtina, Ekaterina
    Muin, Dina
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2025, 35 (01) : 103 - 107
  • [5] Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma
    Samson, Patrick
    Smith, Arthur D.
    Hoenig, David
    Okeke, Zeph
    JOURNAL OF ENDOUROLOGY, 2018, 32 : S10 - S16
  • [6] Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma
    Grahn, Alexandra
    Tanaka, Nobuyuki
    Uhlen, Per
    Brehmer, Marianne
    WORLD JOURNAL OF UROLOGY, 2019, 37 (11) : 2297 - 2302
  • [7] Upper tract urothelial carcinoma
    Ma, Yanchun
    Melzer, Michael Karl
    Zengerling, Friedemann
    Wezel, Felix
    Bolenz, Christian
    ONKOLOGIE, 2025, 31 (01): : 112 - 122
  • [8] Genomic Characterization of Upper Tract Urothelial Carcinoma
    Sfakianos, John P.
    Cha, Eugene K.
    Iyer, Gopa
    Scott, Sasinya N.
    Zabor, Emily C.
    Shah, Ronak H.
    Ren, Qinghu
    Bagrodia, Aditya
    Kim, Philip H.
    Hakimi, A. Ari
    Ostrovnaya, Irina
    Ramirez, Ricardo
    Hanrahan, Aphrothiti J.
    Desai, Neil B.
    Sun, Arony
    Pinciroli, Patrizia
    Rosenberg, Jonathan E.
    Dalbagni, Guido
    Schultz, Nikolaus
    Bajorin, Dean F.
    Reuter, Victor E.
    Berger, Michael F.
    Bochner, Bernard H.
    Al-Ahmadie, Hikmat A.
    Solit, David B.
    Coleman, Jonathan A.
    EUROPEAN UROLOGY, 2015, 68 (06) : 970 - 977
  • [9] Management of upper urinary tract urothelial carcinoma
    Sun, Maxine
    Abdo, Al'a
    Abdollah, Firas
    Schmitges, Jan
    Thuret, Rodolphe
    Jeldres, Claudio
    Shariat, Shahrokh F.
    Perrotte, Paul
    Karakiewicz, Pierre I.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (12) : 1955 - 1965
  • [10] Diagnosis and management of upper tract urothelial carcinoma
    Krabbe, L. -M.
    Bagrodia, A.
    Westerman, M. E.
    Margulis, V.
    MINERVA UROLOGICA E NEFROLOGICA, 2014, 66 (01) : 37 - 48